Danaher Strengthens Commitment to Greater Bay Area with New Headquarters on Guangzhou Bio Island to Advance Biomedical Industry

GUANGZHOU, June 30, 2021 /PRNewswire/ -- On June 29, 2021, Huangpu District and the Guangzhou Development District held a centralized groundbreaking ceremony for urban renewal projects, alongside an event for the signing, completion, and trial production of major projects. Danaher, a global science and technology innovator, signed a letter of intent for strategic cooperation with the People's Government of Huangpu District, Guangzhou Municipality / the Administrative Committee of Guangzhou Development District, with plans to establish the Danaher Greater Bay Area headquarters on Guangzhou International Bio Island to jointly advance industrial development.

Danaher and the People's Government of Huangpu District, Guangzhou / Guangzhou Development District Management Committee Sign Strategic Cooperation Intent to Establish Danaher Greater Bay Area Headquarters on Guangzhou International Bio Island, Jointly Promoting Industrial Development

Accelerate Localization, Drive Regional Economic and Healthcare Industry Development

In recent years, Huangpu District and Guangzhou Development District, by focusing on national platforms and expanding space for industrial development, have formed“The “Two Cities and One Island” biopharmaceutical industry development framework, backed by a series of supporting mechanisms and policy guarantees, has gradually emerged as a first-tier force in China’s biopharmaceutical sector. As a comprehensive biotechnology industry development project serving as a powerful engine for Guangzhou’s innovation-driven growth, Guangzhou International Bio Island has established a complete support service system. It has fostered a research and industrial cluster with advanced technological development capabilities and a distinctive biotechnology research environment, positioning itself as an internationally advanced biopharmaceutical R&D base. This ecosystem will provide fertile ground and sustained industrial momentum for the future development of settled enterprises.

As an innovation-driven technology corporation, Danaher’s portfolio of companies and brands holds leading positions in their respective niche markets. The establishment of Danaher’s Greater Bay Area headquarters at Guangzhou Bio Island represents a key strategic initiative in upgrading its localization strategy in China. Driven by the unique demands of the Chinese market, Danaher continuously enhances its local R&D and manufacturing capabilities. By operating closer to customers and the market, the company delivers superior value-added services to local clients, striving to realize its strategic goal of “Based in China, Serving China.” In this context, a comprehensive industrial ecosystem is vital to the success of Danaher’s localization strategy.

Peng Yang, President of Danaher Greater China and President of Danaher Diagnostics China, stated: “The establishment of Danaher’s Guangdong-Hong Kong-Macao Greater Bay Area Headquarters represents a key strategic deployment for Danaher in the South China market. Throughout this process, we have felt firsthand the strong support from the Huangpu District Government and the Development Zone Management Committee. This deepened cooperation between Danaher and the City of Guangzhou serves as further testament to our continued commitment to the Chinese market and our comprehensive support for China’s regional economic development.”

Through a strategic alliance that leverages their combined strengths in industrial development, resources, and innovation, the two parties have established a comprehensive partnership in the life sciences and medical diagnostics sectors. Spanning multiple dimensions including ecosystem collaboration, industrial incubation, innovation acceleration, talent development, and intellectual property protection, this multi-faceted cooperation will create a win-win mechanism to drive the development of the pharmaceutical and healthcare ecosystem in the Guangdong-Hong Kong-Macao Greater Bay Area.

Multi-Ecosystem Collaboration: Jointly Expanding the Growth Potential of the Pharmaceutical Industry

Danaher's Greater Bay Area Headquarters will primarily cover the South China market, including Hong Kong and Macau, with a strategic focus on the biopharmaceutical sector and vaccine research and production. In the future, beyond its office functions, the headquarters will also serve as a platform for brand showcase, industry exchange, and collaborative investment promotion with the park. By fully leveraging its end-to-end solutions, it will enhance the platform's clustering effect and facilitate the upgrading of Bio Island's pharmaceutical industry development capacity.

In addition, Danaher will co-host a series of events themed around the "Belt and Road" Initiative with the Development Zone. Focusing on R&D innovation, clinical collaboration, industrialization, and market applications in related fields such as life sciences and medical diagnostics, these initiatives will jointly promote the commercialization of life science achievements and industrial advancement, assist Chinese enterprises in expanding globally, and enable life science technologies to better benefit the public. Regarding industrial incubation, Danaher will also explore collaboration with the China-Israel Base in Bio Island and the China-Israel Fund. Through various initiatives including project screening, project roadshows, technology transfer, incubation investment, and accelerator programs, Danaher will advance the commercialization of scientific and technological innovations in the Greater Bay Area.

Li Bing, President of Danaher Life Sciences Platform, China, stated: “Guangdong is one of the strategic centers for the development of China's biopharmaceutical industry. The High-tech Zone serves as a key cluster for Guangzhou's biopharmaceutical sector and the core area of the National Biotechnology Industry Base, from where multiple innovative biologics have already expanded to global markets. Several operating companies under the Danaher Life Sciences Platform will establish operations on Bio Island, and will fully leverage the platform's ecosystem to help accelerate China's biopharmaceutical industry in securing a commanding global position.”

Vaccines have played a pivotal role in global public health emergencies. Danaher will also explore multi-level cooperation in the vaccine sector with the Development Zone government, including partnering with state-owned vaccine industrial parks to establish R&D, testing, and manufacturing platforms, thereby empowering vaccine R&D and production enterprises in China as well as upstream and downstream industry partners.

In terms of talent development, Danaher will fully support the Guangzhou Bioprocessing Technology Training Institute, further expanding cooperation in curriculum development, talent cultivation, and the establishment of training equipment platforms. By introducing the Danaher Business System (DBS) training system, it aims to cultivate biopharmaceutical professionals for the Greater Bay Area and enhance industrial efficiency. In late 2019, Cytiva, a Danaher operating company, and the Guangzhou Development District Government jointly invested USD 10 million to establish a new biopharmaceutical talent cultivation base on Guangzhou Bio Island—the Guangzhou Bioprocessing Technology Institute. Focusing on the cultivation of applied talents in Guangdong Province's biopharmaceutical sector, the institute provides GMP-compliant training services to support biopharmaceutical enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area in achieving international development.

Yu Lihua, General Manager of Cytiva Greater China, stated: “In less than a year since its establishment, the Guangzhou Bioprocess Manufacturing Research & Training Institute has already supported the training of successive cohorts of highly skilled professionals. We will continue to leverage Cytiva's technical expertise and resource advantages in the biopharmaceutical sector, collaborate with industry stakeholders, and help more local talents and enterprises internationalize their skills and technologies.”

In the dynamic and innovative environment of Guangzhou Bio-island, Danaher aims to achieve mutual success through diversified collaboration with government authorities, institutions, and enterprises, jointly fostering an innovation ecosystem, promoting the development of the Guangdong-Hong Kong-Macao Greater Bay Area, and actively contributing to the advancement of China's pharmaceutical and healthcare industry.